BallestÃn, P.; López de Sá, A.; DÃaz-Tejeiro, C.; Paniagua-Herranz, L.; Sanvicente, A.; López-Cade, I.; Pérez-Segura, P.; Alonso-Moreno, C.; Nieto-Jiménez, C.; Ocaña, A.
Understanding the Toxicity Profile of Approved ADCs. Pharmaceutics 2025, 17, 258.
https://doi.org/10.3390/pharmaceutics17020258
AMA Style
BallestÃn P, López de Sá A, DÃaz-Tejeiro C, Paniagua-Herranz L, Sanvicente A, López-Cade I, Pérez-Segura P, Alonso-Moreno C, Nieto-Jiménez C, Ocaña A.
Understanding the Toxicity Profile of Approved ADCs. Pharmaceutics. 2025; 17(2):258.
https://doi.org/10.3390/pharmaceutics17020258
Chicago/Turabian Style
BallestÃn, Pablo, Alfonso López de Sá, Cristina DÃaz-Tejeiro, LucÃa Paniagua-Herranz, Adrián Sanvicente, Igor López-Cade, Pedro Pérez-Segura, Carlos Alonso-Moreno, Cristina Nieto-Jiménez, and Alberto Ocaña.
2025. "Understanding the Toxicity Profile of Approved ADCs" Pharmaceutics 17, no. 2: 258.
https://doi.org/10.3390/pharmaceutics17020258
APA Style
BallestÃn, P., López de Sá, A., DÃaz-Tejeiro, C., Paniagua-Herranz, L., Sanvicente, A., López-Cade, I., Pérez-Segura, P., Alonso-Moreno, C., Nieto-Jiménez, C., & Ocaña, A.
(2025). Understanding the Toxicity Profile of Approved ADCs. Pharmaceutics, 17(2), 258.
https://doi.org/10.3390/pharmaceutics17020258